Hidden Disease

Current diagnosis measures blood sugars. Even those with severe diabetic complications often have blood sugars that are OK. So what is the problem? Well, testing has not been adequate except in research situations. Measurements of insulin levels and other biomarkers for diabetes and prediabetes are not readily available.  In addition, measurements of metabolic impairment have not been readily available either. 

We have been measuring and collecting data on metabolic impairment since 1996 with breath testing and respiratory quotients to evaluate the ability to process carbohydrates and how to monitor therapy. 

Recently we are researching the use of breath analysis with volatile organic compounds such as acetone, methyl nitrate, and isoprene to evaluate metabolic problems. Since insulin resistance causes inflammation, we are seeking new ways to obtain direct and indirect measurements of inflammation to better evaluate metabolic states. 

The exciting news is that soon we hope we can launch a way to do these tests as inexpensive  Point of Care tests in doctors’ offices and home tests using cell phones that are monitored via the internet and the patients’ health care professional.